When Is Door-to-Balloon Time Critical? Analysis From the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trials

Authors

Bruce R. Brodie MDFollow
Bernard J. Gersh MB, ChB, DPhilFollow
Thomas D. Stuckey MD
Bernhard Witzenbichler MD
Giulio Guagliumi MD
Jan Z. Peruga MD
Dariusz Dudek MDFollow
Cindy L. Grines MDFollow
David A. Cox MD, Lehigh Valley Health NetworkFollow
Helen Parise ScD
Abhiram Prasad MD
Alexandra J. Lansky MD
Roxana Mehran MD
Gregg W. Stone MD

Publication/Presentation Date

7-27-2010

Volume

56

Issue

5

First Page

1168

Last Page

1168

ISSN

07351097

Published In/Presented At

Brodie, B., Gersh, B., Stuckey, T., Witzenbichler, B., Guagliumi, G., Peruga, J., & ... Stone, G. (2010). When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials. Journal Of The American College Of Cardiology, 56(5), 407-413. doi:10.1016/j.jacc.2010.04.020

Disciplines

Cardiology | Medical Sciences | Medical Specialties | Medicine and Health Sciences

PubMedID

20650362

LVHN link

http://search.ebscohost.com/login.aspx?direct=true&db=mnh&AN=20650362&site=ehost-live&scope=site

Department(s)

Department of Medicine, Cardiology Division

Document Type

Article